Department ofInternal Medicine, Emory University Hospital, Georgia, United States
Case Report
A Case Report: Antibody Response to 2-Dose Pfizer Vaccine and Johnson and Johnson Vaccine in a Kidney Transplant Patient
Author(s): Gita Taasoobshirazi*, Shiva Zaman and Katayun Taasoobshirazi
Recent research has shown that immunocompromised individuals are less likely to build detectible SARS-CoV-2 spike
protein antibodies after vaccination. This is distressing for the 11.5 million individuals on some form of
immunosuppressive therapy as the SARS-CoV-2 virus can lead to more severe illness and greater risk for death among
these individuals. This study fills a gap in the research on COVID-19 vaccination in immunocompromised
individuals with a case study of how a kidney transplant patient responded to a series of COVID-19 vaccines. The
case study presented in this paper introduces the vaccination schedule and antibody testing of a kidney transplant
patient in effort to assess the efficacy of a series of SARS-CoV-2 vaccines. The patient did not make SARS-CoV-2
spike protein antibodies, as assessed by a Spike Protein IgG Antibody blood test, after a two-do.. View more»